Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth

Title: The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
Authors: Kishor Pant; Seth Richard; Estanislao Peixoto; Jun Yin; Davis M. Seelig; Pietro Carotenuto; Massimiliano Salati; Brunella Franco; Lewis R. Roberts; Sergio A. Gradilone
Source: Cells, Vol 12, Iss 5, p 775 (2023)
Publisher Information: MDPI AG
Publication Year: 2023
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: NAMPT; NAD; FK866; Cholangiocarcinoma; cisplatin; Cytology; QH573-671
Description: It is well established that Cholangiocarcioma (CCA) drug resistance plays a crucial role in the spread and survival of cancer cells. The major enzyme in the nicotinamide-adenine dinucleotide (NAD+)-mediated pathways, nicotinamide phosphoribosyltransferase (NAMPT), is essential for cancer cell survival and metastasis. Previous research has shown that the targeted NAMPT inhibitor FK866 reduces cancer cell viability and triggers cancer cell death; however, whether FK866 affects CCA cell survival has not been addressed before. We show herein that NAMPT is expressed in CCA cells, and FK866 suppresses the capacity of CCA cells to grow in a dose-dependent manner. Furthermore, by preventing NAMPT activity, FK866 significantly reduced the amount of NAD+ and adenosine 5′-triphosphate (ATP) in HuCCT1, KMCH, and EGI cells. The present study’s findings further show that FK866 causes changes in mitochondrial metabolism in CCA cells. Additionally, FK866 enhances the anticancer effects of cisplatin in vitro. Taken together, the results of the current study suggest that the NAMPT/NAD+ pathway may be a possible therapeutic target for CCA, and FK866 may be a useful medication targeting CCA in combination with cisplatin.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/2073-4409/12/5/775; https://doaj.org/toc/2073-4409; https://doaj.org/article/30ad4730341c47b49dd553c4ebcde208
DOI: 10.3390/cells12050775
Availability: https://doi.org/10.3390/cells12050775; https://doaj.org/article/30ad4730341c47b49dd553c4ebcde208
Accession Number: edsbas.BC601CC6
Database: BASE